Albemarle (NYSE:ALB) Given New $132.00 Price Target at Mizuho

Albemarle (NYSE:ALBFree Report) had its price target raised by Mizuho from $110.00 to $132.00 in a research report released on Thursday, Marketbeat reports. They currently have a neutral rating on the specialty chemicals company’s stock.

A number of other brokerages have also recently commented on ALB. Zacks Research cut Albemarle from a “strong-buy” rating to a “hold” rating in a report on Wednesday, November 5th. Cowen reaffirmed a “hold” rating on shares of Albemarle in a research report on Thursday, October 9th. Scotiabank lifted their price target on shares of Albemarle from $70.00 to $85.00 and gave the company a “sector perform” rating in a research report on Monday, November 10th. Rothschild Redb raised Albemarle to a “strong-buy” rating in a research report on Friday, October 24th. Finally, Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Albemarle in a report on Monday. One equities research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, eighteen have assigned a Hold rating and two have assigned a Sell rating to the company. Based on data from MarketBeat.com, Albemarle has a consensus rating of “Hold” and an average target price of $118.75.

Check Out Our Latest Stock Report on ALB

Albemarle Stock Performance

Shares of ALB opened at $140.44 on Thursday. The company has a 50-day simple moving average of $111.93 and a 200-day simple moving average of $87.42. Albemarle has a 52-week low of $49.43 and a 52-week high of $140.78. The company has a quick ratio of 1.51, a current ratio of 2.27 and a debt-to-equity ratio of 0.40. The company has a market capitalization of $16.53 billion, a PE ratio of -88.33 and a beta of 1.43.

Albemarle (NYSE:ALBGet Free Report) last announced its quarterly earnings results on Wednesday, November 5th. The specialty chemicals company reported ($0.19) EPS for the quarter, topping the consensus estimate of ($0.92) by $0.73. The business had revenue of $1.31 billion for the quarter, compared to analyst estimates of $1.27 billion. Albemarle had a positive return on equity of 0.10% and a negative net margin of 0.43%.The company’s quarterly revenue was down 3.5% on a year-over-year basis. During the same quarter in the previous year, the company earned ($1.55) EPS. Equities research analysts predict that Albemarle will post -0.04 earnings per share for the current fiscal year.

Albemarle Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, January 2nd. Shareholders of record on Friday, December 12th will be given a $0.405 dividend. The ex-dividend date of this dividend is Friday, December 12th. This represents a $1.62 annualized dividend and a yield of 1.2%. Albemarle’s dividend payout ratio (DPR) is currently -101.89%.

Hedge Funds Weigh In On Albemarle

Hedge funds and other institutional investors have recently made changes to their positions in the business. Manning & Napier Advisors LLC acquired a new position in Albemarle during the 3rd quarter worth $138,723,000. ProShare Advisors LLC grew its stake in shares of Albemarle by 48.5% in the 2nd quarter. ProShare Advisors LLC now owns 2,870,110 shares of the specialty chemicals company’s stock worth $179,870,000 after purchasing an additional 937,538 shares during the last quarter. AQR Capital Management LLC increased its holdings in shares of Albemarle by 22,047.4% in the second quarter. AQR Capital Management LLC now owns 713,812 shares of the specialty chemicals company’s stock valued at $44,613,000 after buying an additional 710,589 shares in the last quarter. Samlyn Capital LLC acquired a new stake in shares of Albemarle during the third quarter worth $47,088,000. Finally, FengHe Fund Management Pte. Ltd. acquired a new stake in Albemarle during the 2nd quarter worth about $32,903,000. 92.87% of the stock is currently owned by institutional investors and hedge funds.

About Albemarle

(Get Free Report)

Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Energy Storage, Specialties and Ketjen. The Energy Storage segment offers lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services.

See Also

Analyst Recommendations for Albemarle (NYSE:ALB)

Receive News & Ratings for Albemarle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Albemarle and related companies with MarketBeat.com's FREE daily email newsletter.